Table 2 Treatment outcomes before and after PCR genotyping on day 28
Item | Kibaha | Ujiji | Total | ||
|---|---|---|---|---|---|
Outcome | DP (n = 88) | ASAQ (n = 69) | DP (n = 88) | ASAQ (n = 88) | N = 333 |
PCR uncorrected | |||||
Day 3 parasitaemia | 0 (0.0%) | 0 (0.0%) | 1 (1.1%) | 0 (0.0%) | 1 (0.3%) |
ETF | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
LPF | 1 (1.2%) | 0 (0) | 0 (0.0%) | 0 (0) | 1 (0.3%) |
LCF | 0 (0) | 0 (0) | 0 (0.0%) | 0 (0) | 0 (0.0%) |
ACPR | 85 (98.8%) | 69 (100%) | 83 (100%) | 88 (100%) | 325 (99.6%) |
Total PP | 86 | 69 | 83 | 88 | 326 |
LFU | 0 (0%) | 0 (0%) | 3 (3.4%) | 0 (0%) | 3 (0.9%) |
WD | 2 (2.3%) | 0 (0%) | 2 (2.3%) | 0 (0%) | 4 (1.2%) |
PCR corrected | |||||
ETF | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
LPF | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
LCF | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
ACPR | 85 (100%) | 69 (100%) | 83 (100%) | 88 (100%) | 325 (100%) |
Total PP | 85 | 69 | 83 | 88 | 325 |
LFU | 0 (0.0%) | 0 (0%) | 3 (3.4%) | 0 (0.0%) | 3 (0.9%) |
WD | 2 (2.3%) | 0 (0.0%) | 2 (2.3%) | 0 (0.0%) | 4 (1.2%) |